Market closed

Wave Life Sciences/$WVE

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Wave Life Sciences

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Ticker

$WVE
Trading on

Industry

Pharmaceuticals

Headquarters

Singapore, Singapore

Employees

267

WVE Metrics

BasicAdvanced
$2.3B
Market cap
-
P/E ratio
-$1.14
EPS
-1.21
Beta
-
Dividend rate
$2.3B
-1.21
$15.84
$3.50
1.2M
1.901
1.821
13.224
18.172
-34.04%
-243.82%
35.048
15.68
15.68
-13.248
-37.29%
36.72%
3.30%
-21.31%

What the Analysts think about WVE

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Wave Life Sciences stock.

WVE Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

WVE Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $WVE

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Wave Life Sciences stock?

Wave Life Sciences (WVE) has a market cap of $2.3B as of December 11, 2024.

What is the P/E ratio for Wave Life Sciences stock?

The price to earnings (P/E) ratio for Wave Life Sciences (WVE) stock is 0 as of December 11, 2024.

Does Wave Life Sciences stock pay dividends?

No, Wave Life Sciences (WVE) stock does not pay dividends to its shareholders as of December 11, 2024.

When is the next Wave Life Sciences dividend payment date?

Wave Life Sciences (WVE) stock does not pay dividends to its shareholders.

What is the beta indicator for Wave Life Sciences?

Wave Life Sciences (WVE) has a beta rating of -1.21. This means that it has an inverse relation to market volatility.